ZIM
CCXI

Zacks Investment Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Zacks Investment Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-79,349
Closed -$589K – 667
2017
Q3 		$589K Buy
+79,349
New +$660K 0.01% 445

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Zacks Investment Management's CCXI Position: Q4 2017 in Review

Zacks Investment Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2017, closing a stake of 79,349 shares — an estimated $589K sold.

Zacks Investment Management first reported a position in CCXI in Q3 2017 and held it in 1 quarter. The position peaked at $589K in Q3 2017. 87 funds tracked by Wall St. Rank hold CCXI as of Q4 2017.

  • Zacks Investment Management reported no remaining ChemoCentryx, Inc. position as of Q4 2017 after selling out during the quarter.
  • Zacks Investment Management sold 79,349 ChemoCentryx, Inc. shares in Q4 2017, an estimated $589K.
  • Zacks Investment Management first reported a position in ChemoCentryx, Inc. in Q3 2017 and held it in 1 quarter.
  • Zacks Investment Management's ChemoCentryx, Inc. position peaked at $589K in Q3 2017.
  • 87 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2017.

Based on Zacks Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.